Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Rapid On-Site Detection of Clarithromycin in Water Using an Evanescent Wave Fluorescence Immunosensor.

Created on 26 Oct 2026

Authors

Wenjing Zhang, Yuru Liu, Jingjing Liu, Feng Long, Hejie Li, Xinyu Zhang, Yuxiang Shi, Chunsheng Li

Published in

Biosensors. Volume 16. Issue 10. Oct 20, 2026. Epub Oct 20, 2026.

Abstract

Clarithromycin (CLA), a widely used macrolide antibiotic and contaminant of emerging concern (CEC), is frequently detected in aquatic environments. Its residues can induce bacterial antibiotic resistance, threatening public health and ecosystems. In this study, we constructed an evanescent wave fluorescence immunoassay for the rapid detection of clarithromycin. It detects CLA in water quickly, sensitively, and in a portable format. The sensor combines evanescent wave fluorescence with an indirect competitive immunoassay. It uses a CLA-bovine serum albumin (BSA) conjugate on an optical fiber bioprobe, along with a Cy5.5-labeled anti-clarithromycin monoclonal antibody (Ka = 7.40 × 109 L/mol) as the signal reporter. After optimization, the assay gave a linear range of 7.50-77.45 μg/L. The LOD was 1.67 μg/L, and the LOQ was 7.50 μg/L. The functionalized fiber bioprobe also held up well in repeated use. It stayed stable for over 200 regeneration cycles, with an RSD of 5.63%. The entire automated detection workflow was completed within 20 min without manual intervention. Real-sample validation was performed using tap water and river water spiked at 10, 30, and 60 μg/L, yielding recoveries ranging from 87.13% to 104.84%, with relative standard deviations below 13.08%. These results were corroborated by ELISA. These attributes, combined with the instrument's portability and the probe's regenerability, render this biosensor a promising analytical platform for on-site environmental monitoring of clarithromycin residues.

PMID:
42930135
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement